Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Altoderm (sodium cromoglicate lotion) in pediatric atopic dermatitis
2004-003901-25Phase 3Completed
- Sponsor
- Thornton & Ross
- Start
- Aug 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of alclometasone in atopic dermatitis (AD) (2 arms), sponsored by Thornton & Ross. Primary endpoint: Change in SCORAD assessment scores. Started Aug 2005; status: completed.
02
Drugs
alclometasone
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2004-003901-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003901-25.